KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 83 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -38.5% | 7,001 | +34.9% | 0.00% | – |
| Q2 2023 | $13 | -18.8% | 5,190 | 0.0% | 0.00% | – |
| Q1 2023 | $16 | -65.2% | 5,190 | -19.8% | 0.00% | – |
| Q4 2022 | $46 | -99.9% | 6,475 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $56,000 | +14.3% | 6,475 | +9.6% | 0.00% | – |
| Q2 2022 | $49,000 | -30.0% | 5,910 | +40.3% | 0.00% | -100.0% |
| Q1 2022 | $70,000 | – | 4,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |